Assessment of the quality of life in patients with chronic hepatitis C treated by inf-based therapy / Hesham Abbass Elhalwagy ; Supervised Ayman Amer , Mohamed Said Abdelaziz , Wafaa Elakel
Material type: TextLanguage: English Publication details: Cairo : Hesham Abbass Elhalwagy , 2014Description: 121 P. ; 25cmOther title:- تقييم جودة الحياة لمرضى الالتهاب الكبدى الفيروسى (ج) المعالجين بعقار الانترفيرون طويل المفعول [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2014.He.A (Browse shelf(Opens below)) | Not for loan | 01010110066175000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2014.He.A (Browse shelf(Opens below)) | 66175.CD | Not for loan | 01020110066175000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
HCV - related chronic liver disease is a major health problem in Egypt which shows the highest prevalence of the disease worldwide. Health - related quality of life (HRQoL) is the main concern of health care professionals and is becoming an important health outcome indicator. As reported by many previous studies that treating HCV patients with Interferon based therapy causes many side effects and also affects the patients{u2019} HRQoL. To Assess of the changes in QoL in Egyptian patient with chronic hepatitis C undergoing treatment with Peg - INF + RBV compared with pre-treatment status and to evaluate the impact of QoL changes on patients undergoing the treatment. A follow up study based on 53 chronic hepatitis C patients receiving Peg - INF + RBV in National treatment program in El Kahira Elfatimia Hospital (one of the affiliated centers to National committee for control of Viral Hepatitis NCCVH, Egypt). Patients were classified according to their end of treatment response into responders n = 39, 73.6% and non - responders n = 14, 26.4%
Issued also as CD
There are no comments on this title.